메뉴 건너뛰기




Volumn 40, Issue 9, 2014, Pages 1340-1351

Erratum to: Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients[Intensive Care Medicine(2014), 40, 1340-1351, DOI 10.1007/s00134-014-3403-8];Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

(15)  De Waele, Jan J a   Lipman, J b,c   Akova, M d   Bassetti, M e   Dimopoulos, G f   Kaukonen, M g,h   Koulenti, D b   Martin, C i   Montravers, P j   Rello, J k   Rhodes, A l   Udy, A A b,m   Starr, T b   Wallis, S C b   Roberts, J A b,c  


Author keywords

Critical care; Pharmacodynamics; Pharmacokinetics; Lactam antibiotics

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFEPIME; CEFTRIAXONE; DORIPENEM; MEROPENEM; PIPERACILLIN; ANTIINFECTIVE AGENT; BETA LACTAM;

EID: 84906935346     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-3772-7     Document Type: Erratum
Times cited : (154)

References (39)
  • 1
    • 40849085072 scopus 로고    scopus 로고
    • Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
    • McKinnon PS, Paladino JA, Schentag JJ (2008) Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents 31:345-351
    • (2008) Int J Antimicrob Agents , vol.31 , pp. 345-351
    • McKinnon, P.S.1    Paladino, J.A.2    Schentag, J.J.3
  • 2
    • 84875273480 scopus 로고    scopus 로고
    • Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia
    • Muller AE, Punt N, Mouton JW (2013) Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia. J Antimicrob Chemother 68:900-906
    • (2013) J Antimicrob Chemother , vol.68 , pp. 900-906
    • Muller, A.E.1    Punt, N.2    Mouton, J.W.3
  • 3
    • 34248328649 scopus 로고    scopus 로고
    • Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections
    • DOI 10.1128/AAC.00294-06
    • Li C, Du X, Kuti JL, Nicolau DP (2007) Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections. Antimicrob Agents Chemother 51:1725-1730 (Pubitemid 46744151)
    • (2007) Antimicrobial Agents and Chemotherapy , vol.51 , Issue.5 , pp. 1725-1730
    • Li, C.1    Du, X.2    Kuti, J.L.3    Nicolau, D.P.4
  • 5
    • 84863807810 scopus 로고    scopus 로고
    • Subtherapeutic initial beta-lactam concentrations in select critically ill patients: Association between augmented renal clearance and low trough drug concentrations
    • Udy AA, Varghese JM, Altukroni M, Briscoe S, McWhinney BC, Ungerer JP, Lipman J, Roberts JA (2012) Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest 142:30-39
    • (2012) Chest , vol.142 , pp. 30-39
    • Udy, A.A.1    Varghese, J.M.2    Altukroni, M.3    Briscoe, S.4    McWhinney, B.C.5    Ungerer, J.P.6    Lipman, J.7    Roberts, J.A.8
  • 6
    • 77954738622 scopus 로고    scopus 로고
    • Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: Special emphasis on unbound pharmacokinetics
    • Ulldemolins M, Roberts JA, Wallis SC, Rello J, Lipman J (2010) Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics. J Antimicrob Chemother 65:1771-1778
    • (2010) J Antimicrob Chemother , vol.65 , pp. 1771-1778
    • Ulldemolins, M.1    Roberts, J.A.2    Wallis, S.C.3    Rello, J.4    Lipman, J.5
  • 9
    • 84877003713 scopus 로고    scopus 로고
    • Meropenem and piperacillin/tazobactam prescribing in critically ill patients: Does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
    • Carlier M, Carrette S, Roberts JA, Stove V, Verstraete AG, Hoste E, Decruyenaere J, Depuydt P, Lipman J, Wallis SC, De Waele JJ (2013) Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used? Crit Care 17:R84
    • (2013) Crit Care , vol.17
    • Carlier, M.1    Carrette, S.2    Roberts, J.A.3    Stove, V.4    Verstraete, A.G.5    Hoste, E.6    Decruyenaere, J.7    Depuydt, P.8    Lipman, J.9    Wallis, S.C.10    De Waele, J.J.11
  • 11
    • 84876410012 scopus 로고    scopus 로고
    • Identifying patients at risk for augmented renal clearance in the ICU - limitations and challenges
    • Carlier M, De Waele JJ (2013) Identifying patients at risk for augmented renal clearance in the ICU - limitations and challenges. Crit Care 17:130
    • (2013) Crit Care , vol.17 , pp. 130
    • Carlier, M.1    De Waele, J.J.2
  • 14
    • 84863431581 scopus 로고    scopus 로고
    • DALI: Defining antibiotic levels in intensive care unit patients: A multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic
    • Roberts JA, De Waele JJ, Dimopoulos G, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J (2012) DALI: defining antibiotic levels in intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic. BMC Infect Dis 12:152
    • (2012) BMC Infect Dis , vol.12 , pp. 152
    • Roberts, J.A.1    De Waele, J.J.2    Dimopoulos, G.3    Koulenti, D.4    Martin, C.5    Montravers, P.6    Rello, J.7    Rhodes, A.8    Starr, T.9    Wallis, S.C.10    Lipman, J.11
  • 16
    • 0030015661 scopus 로고    scopus 로고
    • The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine
    • Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707-710
    • (1996) Intensive Care Med , vol.22 , pp. 707-710
    • Vincent, J.L.1    Moreno, R.2    Takala, J.3    Willatts, S.4    De Mendonca, A.5    Bruining, H.6    Reinhart, C.K.7    Suter, P.M.8    Thijs, L.G.9
  • 17
    • 84855393537 scopus 로고    scopus 로고
    • Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story
    • Lipman J, Udy AA, Roberts JA (2011) Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story. Anaesth Intensive Care 39:999-1000
    • (2011) Anaesth Intensive Care , vol.39 , pp. 999-1000
    • Lipman, J.1    Udy, A.A.2    Roberts, J.A.3
  • 18
    • 84888203416 scopus 로고    scopus 로고
    • Clinical implications of antibiotic pharmacokinetic principles in the critically ill
    • Udy AA, Roberts JA, Lipman J (2013) Clinical implications of antibiotic pharmacokinetic principles in the critically ill. Intensive Care Med 39:2070-2082
    • (2013) Intensive Care Med , vol.39 , pp. 2070-2082
    • Udy, A.A.1    Roberts, J.A.2    Lipman, J.3
  • 19
    • 33846442436 scopus 로고    scopus 로고
    • Piperacillin-tazobactam for Pseudomonas aeruginosa infection: Clinical implications of an extended-infusion dosing strategy
    • DOI 10.1086/510590
    • Lodise TP Jr, Lomaestro B, Drusano GL (2007) Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis 44:357-363 (Pubitemid 46147617)
    • (2007) Clinical Infectious Diseases , vol.44 , Issue.3 , pp. 357-363
    • Lodise Jr., T.P.1    Lomaestro, B.2    Drusano, G.L.3
  • 20
    • 70249113663 scopus 로고    scopus 로고
    • Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients
    • Shea KM, Cheatham SC, Wack MF, Smith DW, Sowinski KM, Kays MB (2009) Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients. Int J Antimicrob Agents 34:429-433
    • (2009) Int J Antimicrob Agents , vol.34 , pp. 429-433
    • Shea, K.M.1    Cheatham, S.C.2    Wack, M.F.3    Smith, D.W.4    Sowinski, K.M.5    Kays, M.B.6
  • 23
    • 28144459346 scopus 로고    scopus 로고
    • Continuous versus intermittent intravenous administration of antibacterials with time-dependent action: A systematic review of pharmacokinetic and pharmacodynamic parameters
    • DOI 10.2165/00003495-200565170-00006
    • Kasiakou SK, Lawrence KR, Choulis N, Falagas ME (2005) Continuous versus intermittent intravenous administration of antibacterials with time-dependent action: a systematic review of pharmacokinetic and pharmacodynamic parameters. Drugs 65:2499-2511 (Pubitemid 41697317)
    • (2005) Drugs , vol.65 , Issue.17 , pp. 2499-2511
    • Kasiakou, S.K.1    Lawrence, K.R.2    Choulis, N.3    Falagas, M.E.4
  • 24
    • 34249866197 scopus 로고    scopus 로고
    • Continuous infusion of beta-lactam antibiotics in severe infections: A review of its role
    • DOI 10.1016/j.ijantimicag.2007.02.002, PII S0924857907000908
    • Roberts JA, Paratz J, Paratz E, Krueger WA, Lipman J (2007) Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role. Int J Antimicrob Agents 30:11-18 (Pubitemid 46874893)
    • (2007) International Journal of Antimicrobial Agents , vol.30 , Issue.1 , pp. 11-18
    • Roberts, J.A.1    Paratz, J.2    Paratz, E.3    Krueger, W.A.4    Lipman, J.5
  • 25
    • 79959337263 scopus 로고    scopus 로고
    • Does prolonged beta-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials
    • Tamma PD, Putcha N, Suh YD, Van Arendonk KJ, Rinke ML (2011) Does prolonged beta-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials. BMC Infect Dis 11:181
    • (2011) BMC Infect Dis , vol.11 , pp. 181
    • Tamma, P.D.1    Putcha, N.2    Suh, Y.D.3    Van Arendonk, K.J.4    Rinke, M.L.5
  • 26
  • 27
    • 84894437155 scopus 로고    scopus 로고
    • Augmented renal clearance in the ICU: Results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations
    • Udy AA, Baptista JP, Lim NL, Joynt GM, Jarrett P, Wockner L, Boots RJ, Lipman J (2014) Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations. Crit Care Med 42:520-527
    • (2014) Crit Care Med , vol.42 , pp. 520-527
    • Udy, A.A.1    Baptista, J.P.2    Lim, N.L.3    Joynt, G.M.4    Jarrett, P.5    Wockner, L.6    Boots, R.J.7    Lipman, J.8
  • 30
    • 84874380062 scopus 로고    scopus 로고
    • Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: Identifying at-risk patients
    • Udy AA, Roberts JA, Shorr AF, Boots RJ, Lipman J (2013) Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients. Crit Care 17:R35
    • (2013) Crit Care , vol.17
    • Udy, A.A.1    Roberts, J.A.2    Shorr, A.F.3    Boots, R.J.4    Lipman, J.5
  • 31
    • 84863278700 scopus 로고    scopus 로고
    • Pharmacokinetics of beta-lactam antibiotics in patients with intra-abdominal disease: A structured review
    • Adnan S, Paterson DL, Lipman J, Kumar S, Li J, Rudd M, Roberts JA (2012) Pharmacokinetics of beta-lactam antibiotics in patients with intra-abdominal disease: a structured review. Surg Infect (Larchmt) 13:9-17
    • (2012) Surg Infect (Larchmt) , vol.13 , pp. 9-17
    • Adnan, S.1    Paterson, D.L.2    Lipman, J.3    Kumar, S.4    Li, J.5    Rudd, M.6    Roberts, J.A.7
  • 33
    • 84886656109 scopus 로고    scopus 로고
    • Dose modulation: A new concept of antibiotic therapy in the critically ill patient?
    • Goncalves-Pereira J, Paiva JA (2013) Dose modulation: a new concept of antibiotic therapy in the critically ill patient? J Crit Care 28:341-346
    • (2013) J Crit Care , vol.28 , pp. 341-346
    • Goncalves-Pereira, J.1    Paiva, J.A.2
  • 37
    • 0036225961 scopus 로고    scopus 로고
    • Can PK/PD be used in everyday clinical practice
    • Scaglione F (2002) Can PK/PD be used in everyday clinical practice. Int J Antimicrob Agents 19:349-353
    • (2002) Int J Antimicrob Agents , vol.19 , pp. 349-353
    • Scaglione, F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.